Sources share that the Promoters are evaluating options to sell Suven Pharma and have hired an investment bank to advise on majority stake sale in the company.
.
“Sale of Suven Pharma is to raise funds for drug development in Suven Life Sciences which have so far been funded by the promoters through dividend earned from Suven Pharma,” a source added.
| Subscribe To Our Free Newsletter |
